Cardiac resynchronization therapy and arterial blood pressure: a bonus for hemodynamic improvement

References

• Ather S, Bangalore S, Vemuri S, Cao LB, Bozkurt B, Messerli FH. Trials on the effect of cardiac resynchronization on arterial blood pressure in patients with heart failure. Am. J. Cardiol.107(4), 561–568 (2011).
   PubMed Web of Science ®Google Scholar
• Vardas PE, Auricchio A, Blanc JJ et al. Guidelines for cardiac pacing and cardiac resynchronization therapy: the Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur. Heart J.28(18), 2256–2295 (2007).
   PubMed Web of Science ®Google Scholar
• Dickstein K, Vardas PE, Auricchio A et al. 2010 Focused Update of ESC Guidelines on device therapy in heart failure: an update of the 2008 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure and the 2007 ESC guidelines for cardiac and resynchronization therapy. Developed with the special contribution of the Heart Failure Association and the European Heart Rhythm Association. Eur. Heart J.31(21), 2677–2687 (2010).
   PubMed Web of Science ®Google Scholar
• Okutucu S, Aytemir K, Evranos B et al. Cardiac resynchronization therapy improves exercise heart rate recovery in patients with heart failure. Europace13(4), 526–532 (2010).
   PubMed Web of Science ®Google Scholar
• Aksoy H, Okutucu S, Aytemir K et al. Improvement in right ventricular systolic function after cardiac resynchronization therapy correlates with left ventricular reverse remodeling. Pacing Clin. Electrophysiol.34(2), 200–207 (2011).
   PubMed Web of Science ®Google Scholar
• Aksoy H, Okutucu S, Kaya EB et al. Clinical and echocardiographic correlates of improvement in left ventricular diastolic function after cardiac resynchronization therapy. Europace12(9), 1256–1261 (2010).
   PubMed Web of Science ®Google Scholar
• Bristow MR, Saxon LA, Boehmer J et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N. Engl. J. Med.350(21), 2140–2150 (2004).
   PubMed Web of Science ®Google Scholar
• St John Sutton MG, Plappert T, Abraham WT et al. Effect of cardiac resynchronization therapy on left ventricular size and function in chronic heart failure. Circulation107(15), 1985–1990 (2003).
   PubMed Web of Science ®Google Scholar
• Cleland JG, Daubert JC, Erdmann E et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N. Engl. J. Med.352(15), 1539–1549 (2005).
   PubMed Web of Science ®Google Scholar
• Lee TT, Chen J, Cohen DJ, Tsao L. The association between blood pressure and mortality in patients with heart failure. Am. Heart J.151(1), 76–83 (2006).
   PubMed Web of Science ®Google Scholar
• Cheng RK, Horwich TB, Fonarow GC. Relation of systolic blood pressure to survival in both ischemic and nonischemic systolic heart failure. Am. J. Cardiol.102(12), 1698–1705 (2008).
   PubMed Web of Science ®Google Scholar
• Stasch JP, Kazda S, Hirth C, Morich F. Role of nisoldipine on blood pressure, cardiac hypertrophy, and atrial natriuretic peptides in spontaneously hypertensive rats. Hypertension10(3), 303–307 (1987).
   PubMed Web of Science ®Google Scholar
• Adamopoulos C, Zannad F, Fay R et al. Ejection fraction and blood pressure are important and interactive predictors of 4-week mortality in severe acute heart failure. Eur. J. Heart Fail.9(9), 935–941 (2007).
   PubMed Web of Science ®Google Scholar
• Rouleau JL, Roecker EB, Tendera M et al. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure: the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. J. Am. Coll. Cardiol.43(8), 1423–1429 (2004).
   PubMed Web of Science ®Google Scholar
• Gheorghiade M, Abraham WT, Albert NM et al. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure. JAMA296(18), 2217–2226 (2006).
   PubMed Web of Science ®Google Scholar
• Tanaka Y, Tada H, Yamashita E et al. Change in blood pressure just after initiation of cardiac resynchronization therapy predicts long-term clinical outcome in patients with advanced heart failure. Circ. J.73(2), 288–294 (2009).
   PubMed Web of Science ®Google Scholar
• Van Bommel RJ, Delgado V, Schalij MJ, Bax JJ. Critical appraisal of the use of cardiac resynchronization therapy beyond current guidelines. J. Am. Coll. Cardiol.56(10), 754–762 (2010).
   PubMed Web of Science ®Google Scholar
• Fantoni C, Raffa S, Regoli F et al. Cardiac resynchronization therapy improves heart rate profile and heart rate variability of patients with moderate to severe heart failure. J. Am. Coll. Cardiol.46(10), 1875–1882 (2005).
   PubMed Web of Science ®Google Scholar
• Adamson PB, Kleckner KJ, Vanhout WL, Srinivasan S, Abraham WT. Cardiac resynchronization therapy improves heart rate variability in patients with symptomatic heart failure. Circulation108(3), 266–269 (2003).
   PubMed Web of Science ®Google Scholar